These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15209698)

  • 41. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [First generic triptan approved].
    MMW Fortschr Med; 2006 Apr; 148(16):62-3. PubMed ID: 16688954
    [No Abstract]   [Full Text] [Related]  

  • 44. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
    Tfelt-Hansen P; Iversen HK
    Ugeskr Laeger; 2006 May; 168(19):1850-3. PubMed ID: 16756800
    [No Abstract]   [Full Text] [Related]  

  • 46. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acute migraine. Sumatriptan-naproxen combination tablets work better than a single substance].
    Kreutzkamp B
    Med Monatsschr Pharm; 2007 Sep; 30(9):348-9. PubMed ID: 17912879
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S; Jabbour JT; Webster CJ; Richardson MS
    Headache; 2004; 44(10):969-77. PubMed ID: 15546259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan.
    Gregor N; Schlesiger C; Akova-Oztürk E; Kraemer C; Husstedt IW; Evers S
    Headache; 2005 Sep; 45(8):1069-72. PubMed ID: 16109122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.
    Goadsby PJ; Dodick DW; Ferrari MD; McCrory DC; Williams P
    Acta Neurol Scand; 2004 Sep; 110(3):137-43. PubMed ID: 15285768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Target doses and titration schedules for migraine preventive medications.
    Evans RW; Bigal ME; Grosberg B; Lipton RB
    Headache; 2006 Jan; 46(1):160-4. PubMed ID: 16412164
    [No Abstract]   [Full Text] [Related]  

  • 53. Frovatriptan and data publication.
    Tfelt-Hansen P
    Headache; 2008 Oct; 48(9):1382-3. PubMed ID: 19006553
    [No Abstract]   [Full Text] [Related]  

  • 54. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating the efficacy of migraine therapy.
    Chawluk JB
    Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Which triptan for which patient?
    Rapoport AM; Tepper SJ; Sheftell FD; Kung E; Bigal ME
    Neurol Sci; 2006 May; 27 Suppl 2():S123-9. PubMed ID: 16688615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical benefits of early triptan therapy for migraine.
    Láinez M
    Cephalalgia; 2004; 24 Suppl 2():24-30. PubMed ID: 15595991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial.
    Søndergaard J; Foged A; Kragstrup J; Gaist D; Gram LF; Sindrup SH; Muckadell HU; Larsen BO; Herborg H; Andersen M
    Scand J Prim Health Care; 2006 Mar; 24(1):16-21. PubMed ID: 16464810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K
    Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute treatment of paediatric migraine: a meta-analysis of efficacy.
    Silver S; Gano D; Gerretsen P
    J Paediatr Child Health; 2008 Jan; 44(1-2):3-9. PubMed ID: 17854415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.